Oculus Innovative Sciences, Inc. Partner, Quinnova Pharmaceuticals, Inc., Launches Microcyn(R)-Based Atrapro(TM) Products

PETALUMA, Calif., Feb. 21, 2012 (GLOBE NEWSWIRE) -- Oculus Innovative Sciences, Inc. (Nasdaq:OCLS) partner, Quinnova Pharmaceuticals, today launched the Atrapro™ family of products formulated from the Microcyn® Technology platform. The two products, Atrapro™ Antipruritic Hydrogel, which reduces the itch, pain, and burning of various dermatoses, and Atrapro Dermal Spray with preservatives, for wound care, are both prescription products that are being promoted to the U.S. dermatology market.